Cytek Biosciences Inc. Common Stock
CTKBUnited States
5 filed reports · 323 financial concepts · 4 earnings calls · 0 media appearances
Filed reports
5 reports · Jun 2025 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 4 | 1,366 | Jun 2025 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 1 | 1,006 | Dec 2025 |
Financial data
323 concepts · 2,372 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial309 concepts · 2,125 facts · Dec 2023 to Jun 2026
- Legal settlement liability16 · Dec 2024 to Jun 2026
- Stockholders equity (US GAAP)14 · Dec 2023 to Jun 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value13 · Dec 2023 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents13 · Dec 2023 to Jun 2026
- Shares of Common Stock withheld related to net share settlement13 · Dec 2023 to Jun 2026
- Stock issued during period value employee stock purchase plan13 · Dec 2023 to Jun 2026
- Temporary equity foreign currency translation adjustments13 · Dec 2023 to Jun 2026
- Allocated share based compensation expense12 · Dec 2023 to Jun 2026
- Amortization of intangible assets12 · Dec 2023 to Jun 2026
- Comprehensive income net of tax12 · Dec 2023 to Jun 2026
- Cost of goods and services sold (US GAAP)12 · Dec 2023 to Jun 2026
- Defined contribution plan employer discretionary contribution amount12 · Dec 2023 to Jun 2026
- Depreciation12 · Dec 2023 to Jun 2026
- General and administrative expense (US GAAP)12 · Dec 2023 to Jun 2026
- Gross profit (US GAAP)12 · Dec 2023 to Jun 2026
- Income tax expense benefit12 · Dec 2023 to Jun 2026
- Interest expense nonoperating12 · Dec 2023 to Jun 2026
- Investment income interest12 · Dec 2023 to Jun 2026
- Litigation settlement interest12 · Dec 2023 to Jun 2026
- Marketable securities unrealized gain loss12 · Dec 2023 to Jun 2026
- Marketing and advertising expense12 · Dec 2023 to Jun 2026
- Net income loss available to common stockholders basic12 · Dec 2023 to Jun 2026
- Net income loss available to common stockholders diluted12 · Dec 2023 to Jun 2026
- Nonoperating income expense12 · Dec 2023 to Jun 2026
Segment10 concepts · 144 facts · Dec 2023 to Jun 2026
- Revenue36 · Dec 2023 to Jun 2026
- Allocated share based compensation expense12 · Dec 2023 to Jun 2026
- Amortization - license & IP expense12 · Dec 2023 to Jun 2026
- Cost of sales (excluding stock-based compensation)12 · Dec 2023 to Jun 2026
- General and administrative (excluding stock-based compensation)12 · Dec 2023 to Jun 2026
- Marketing (excluding stock-based compensation)12 · Dec 2023 to Jun 2026
- Net income loss12 · Dec 2023 to Jun 2026
- Research and development (excluding stock-based compensation)12 · Dec 2023 to Jun 2026
- Sales (excluding stock-based compensation)12 · Dec 2023 to Jun 2026
- Segment reporting other item amount12 · Dec 2023 to Jun 2026
Geography1 concepts · 54 facts · Dec 2023 to Jun 2026
- Revenue54 · Dec 2023 to Jun 2026
Product3 concepts · 49 facts · Dec 2023 to Jun 2026
- Cost of goods and services sold (US GAAP)24 · Dec 2023 to Jun 2026
- Revenue24 · Dec 2023 to Jun 2026
- Deferred revenue revenue recognized11 · Dec 2023
Segments
247 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments1 member · 144 facts
- Reportable144 · Dec 2023 to Jun 2026
Statement geographical5 members · 54 facts
- Asia Pacific12 · Dec 2023 to Jun 2026
- EMEA12 · Dec 2023 to Jun 2026
- Other12 · Dec 2023 to Jun 2026
- US12 · Dec 2023 to Jun 2026
- CN6 · Mar 2025 to Jun 2026
Product or service2 members · 49 facts
- Product25 · Dec 2023 to Jun 2026
- Service24 · Dec 2023 to Jun 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
4 calls · Nov 2025 to Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 5, 2026
- FY2026 Q1May 7, 2026
- FY2025 Q4Feb 26, 2026
- FY2025 Q3Nov 5, 2025
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.